Three months ended October 31, 2012

Clinical
Labs

Life
Sciences

Therapeutics

Other

Consolidated

Revenues:

Clinical laboratory services

$

15,177

—

—

—

$

15,177

Product revenues

—

$

8,434

—

—

8,434

Royalty and license fee income

—

2,019

—

—

2,019

15,177

10,453

—

—

25,630

Operating expenses:

Cost of clinical laboratory services

9,710

—

—

—

9,710

Cost of product revenues

—

4,184

—

—

4,184

Research and development

89

606

$

316

—

1,011

Selling, general and administrative

4,961

4,272

—

$

2,182

11,415

Provision for uncollectible accounts receivable

1,556

38

—

—

1,594

Legal

107

6

—

1,587

1,700

Total operating expenses

16,423

9,106

316

3,769

29,614

Operating (loss) income

(1,246

)

1,347

(316

)

(3,769

)

(3,984

)

Other income (expense)

Interest

(9

)

(1

)

—

1

(9

)

Other

6

1

—

2

9

Foreign currency gain

—

229

—

—

229

Income (loss) before income taxes

$

(1,249

)

$

1,576

$

(316

)

$

(3,766

)

$

(3,755

)

Depreciation and amortization included above

$

308

$

813

$

7

$

21

$

1,149

Share-based compensation included in above:

Cost of clinical laboratory services

$

2

—

—

—

$

2

Research and development

—

$

1

—

—

1

Selling, general and administrative

11

—

—

$

128

139

Total

$

13

$

1

—

$

128

$

142

Capital expenditures

$

205

$

86

—

$

—

$

291

Three months ended October 31, 2011

Clinical
Labs

Life
Sciences

Therapeutics

Other

Consolidated

Revenues:

Clinical laboratory services

$

14,187

—

—

—

$

14,187

Product revenues

—

$

9,704

—

—

9,704

Royalty and license fee income

—

1,862

—

—

1,862

14,187

11,566

—

—

25,753

Operating expenses:

Cost of clinical laboratory services

8,814

—

—

—

8,814

Cost of product revenues

—

5,137

—

—

5,137

Research and development

44

1,048

$

533

—

1,625

Selling, general and administrative

4,831

5,228

—

$

2,326

12,385

Provision for uncollectible accounts receivable

1,273

13

—

—

1,286

Legal

43

383

—

442

868

Total operating expenses

15,005

11,809

533

2,768

30,115

Operating loss

(818

)

(243

)

(533

)

(2,768

)

(4,362

)

Other income (expense)

Interest

(1

)

(1

)

—

—

(2

)

Other

5

(5

)

—

9

9

Foreign exchange gain

—

29

—

—

29

Loss before income taxes

$

(814

)

$

(220

)

$

(533

)

$

(2,759

)

$

(4,326

)

Depreciation and amortization included above

$

266

$

914

$

11

$

31

$

1,222

Share-based compensation included in above:

Cost of clinical laboratory services

$

2

—

—

—

$

2

Research and development

—

$

3

—

—

3

Selling, general and administrative

13

20

—

$

175

208

Total

$

15

$

23

—

$

175

$

213

Capital expenditures

$

215

$

30

—

$

7

$

252